Compounds > p(1),p(5)-di(adenosine-5'-)pentaphosphate
Page last updated: 2024-09-03

p(1),p(5)-di(adenosine-5'-)pentaphosphate and bradykinin

p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with bradykinin in 1 studies

Compound Research Comparison

Studies
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)		Trials
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)		Recent Studies (post-2010)
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)		Studies
(bradykinin)		Trials
(bradykinin)		Recent Studies (post-2010) (bradykinin)
21522614,1953551,520

Protein Interaction Comparison

ProteinTaxonomyp(1),p(5)-di(adenosine-5'-)pentaphosphate (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dolhun, B; Geiger, JD; Haughey, NJ; Holden, CP; Nath, A; Shepel, PN1

Other Studies

1 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and bradykinin

ArticleYear
Diadenosine pentaphosphate increases levels of intracellular calcium in astrocytes by a mechanism involving release from caffeine/ryanodine- and IP3-sensitive stores.
    Journal of neuroscience research, 2000, Jan-15, Volume: 59, Issue:2

    Topics: Adenosine Triphosphate; Astrocytes; Bradykinin; Caffeine; Calcium; Central Nervous System Stimulants; Dinucleoside Phosphates; Extracellular Space; Fetus; Humans; Inositol 1,4,5-Trisphosphate; Macrocyclic Compounds; Oxazoles; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Ryanodine; Ryanodine Receptor Calcium Release Channel; Vasoconstrictor Agents

2000